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Background: One of the commonest causes of pulmonary hypertension (PH) is left heart 
dysfunction associated with elevated pulmonary capillary wedge pressure (PCWP). In contrast, 
the pathology of pulmonary arterial hypertension (PAH) originates in the pulmonary vascular 
bed. Accurate diagnosis of PAH requires right heart catheterization (RHC) with normal PCWP. 
This study examines the role of computed tomography of the chest (CT chest) in evaluating left 
atrial (LA) size as an indicator of elevated PCWP in patients undergoing PH evaluation.
Methods: CT chest and RHC data were reviewed in 37 subjects at the Baylor PH Center. Both 
subjective estimates and objective measurements of left atrial size from the CT chest were 
recorded separately by 3 investigators. Patients were categorized as Group I (small-normal LA) 
and Group II (large LA) and RHC results compared.The objective and subjective measurements 
were compared by receiver operator characteristic (ROC).
Results: The mean PCWP was 12 ± 6 mmHg in Group I and 21 ± 7 mmHg in Group II 
(P = 0.001). The estimated LA area was 19.4 ± 4.9 cm2 in Group I and 39.9 ± 7.6 cm2 in 
Group II (mean ± SD; P  0.001). The estimated LA area, corrected for the chest wall length, 
was 0.78 ± 0.19 cm2 and 1.65 ± 0.26 cm2 in Groups I and II, respectively (P  0.001). Signifi-
cant correlations were found between uncorrected PCWP and LA area (R = 0.45, P = 0.005), 
corrected PCWP and LA area (R = 0.47, P = 0.003), and the subjective observer impression of 
LA enlargement and measured PCWP (R = 0.51, P = 0.001).
Conclusion: In this pilot study, enlarged LA area on the CT chest was associated with an 
elevated PCWP on RHC. For patients undergoing PH evaluation, increased LA area on CT 
chest could suggest left heart dysfunction in patients as a possible cause of PH.
Keywords: pulmonary capillary wedge pressure, diastolic dysfunction, right heart 
catheterization, radiology, left atrial area
Introduction
Pulmonary arterial hypertension (PAH) is a devastating disease with 50% mortality 
at 2.8 years in patients left untreated or unresponsive to treatment.1 Diagnostic evalu-
ation in patients with pulmonary hypertension (PH) includes an echocardiogram, 
which when performed as it routinely undertaken even in tertiary referral centers, 
will diagnose an elevated pulmonary artery pressure. Patients are frequently misdi-
agnosed as having PAH (diagnostic group I classification [ie, PAH]) and started on 
PAH-specific therapy based on an echocardiogram in the absence of a right heart 
catheterization (RHC). When the diagnostic cardiac catheterization is subsequently 
undertaken, many patients referred for evaluation and treatment of PAH have 
an elevated pulmonary capillary wedge pressure (PCWP), suggesting left heart International Journal of General Medicine 2010:3 24
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dysfunction (LHD) (diagnostic group II classification) as a 
cause of PH.2,3 The distinction is important as the prognosis 
and therapy are different between these two disorders.4
The diagnosis of PAH requires a normal PCWP, or a 
normal left ventricular end-diastolic pressure at the time of 
cardiac catheterization.5 Elevated PCWP may be an indicator 
of LHD in patients with preserved ejection fraction. LHD 
is considered a frequent cause of PH.2,6 Left atrial (LA) 
size is considered a marker of LHD with preserved ejection 
fraction.7–10 We undertook this study to examine the role of 
computed tomography of the chest (CT chest) in evaluating 
LA size as an indicator of PCWP in patients undergoing PH 
evaluation. Our hypothesis was that a LA appearing large 
on the CT chest would be an indicator of elevated PCWP 
during a RHC in patients with normal ejection fraction (EF) 
(40%) and normal aortic and mitral valves.
Methods
After obtaining institutional review board approval, a retro-
spective study was undertaken of those patients evaluated for 
PAH and underwent a right heart catheterization at Baylor 
College of Medicine Pulmonary Hypertension Center from 
July 1, 2005 to June 30, 2006. At this center, CT chest and 
echocardiography are routine evaluations undertaken for 
suspected PH. RHC is the gold standard to confirm the diag-
nosis of pulmonary hypertension. We identified 63 patients 
who underwent RHC for PH evaluation. Of those patients, 
26 were excluded from analysis, 20 due to the absence of a 
recent (defined as ± 60 days) CT chest; 3 due to the presence 
of congenital intra-cardiac shunts which frequently are 
associated with LA enlargement; 1 due to the presence of 
lung cancer and significant pleural effusion; and 1 due to 
failure to obtain PCWP.
CT chests from the remaining 37 patients were reviewed 
on the Picture Archiving and Communications Systems 
by 3 independent investigators (adult pulmonologists), 
2 of whom were blinded to the name, cardiac catheteriza-
tion results, and diagnosis of the subjects (MK and AF). 
Subjective impression of LA size (graded as small-normal 
or large) was recorded (Figure 1). Approximate LA area 
was measured as follows: LA area was measured in the 
mediastinal window at the point where LA appeared largest 
to the reader (Figure 1); horizontal length (L) and vertical 
width (W) of the LA were measured; LA area was calculated 
(LA area = L × W). LA area was corrected for patient size 
by dividing the calculated area of the LA by the horizontal 
chest wall length (Lcw), measured in the same plane and along 
the same line as the measurement of the horizontal length 
of the LA (corrected LA = [L × W]/Lcw) (Figure 1).
The impression of the LA by each investigator was 
recorded and grouped as either small-normal (Group I) 
or large (Group II) (Figure 1). When there was agreement 
between two investigators and disagreement with the third, 
the impression of the 2 agreeing investigators was accepted. 
RHC had been undertaken in patients with normal mitral 
and aortic valves on echocardiogram with preserved left 
ventricular (LV) systolic function (ie, no evidence of LV 
systolic failure). Echocardiograms were done at the referral 
center. No specific instructions were given to the echocar-
diographers. The provided diagnosis was “PH”, therefore, 
all measurements were the standard evaluations undertaken 
for a diagnosis of PH.
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Figure 1 computed tomography of chest at the level of left atrium in pulmonary arterial hypertension A) and diastolic dysfunction B) LA size and measurement were 
determined at the level where the LA appeared largest to the investigator.  A) small appearing LA; B) Large appearing LA.
Abbreviations: LA, left atrium; LcW , horizontal chest wall length; LAL, horizontal length of LA; LAW, vertical length of LA.International Journal of General Medicine 2010:3 25
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Statistical analysis
Data are presented as mean ± SD. Comparisons of all 
measurements between the two groups were made with 
unpaired t-test. Values were considered significantly different 
at P  0.05. Pearson correlation analyses of clinical and 
hemodynamic parameters with LA area and impression of 
investigators were performed with SPSS software. Shrout-
Fleiss intra-class correlation coefficient was used to measure 
the inter-rater reliability among the 3 investigators.
Results
Subjective evaluation of LA size
There were 29 subjects in Group I and 8 in Group II. The 
inter-rater reliability calculated using the Shrout-Fleiss intra-
class correlation for LA area was 0.865, indicating acceptable 
level of agreement among investigators.
The baseline characteristics of these subjects are out-
lined in Table 1. The estimated LA area was 19.4 ± 4.9 cm2 
in Group I and 39.9 ± 7.6 cm2 in Group II (mean ± SD; 
P  0.001) (Table 2A). The estimated LA areas corrected for 
the chest wall length (L × W/Lcw) were 0.78 ± 0.19 cm2 and 
1.65 ± 0.26 cm2 (P  0.001) in Groups I and II, respectively 
(Table 2B). There was no significant difference in the 
mean pulmonary artery pressures between the two groups 
(P = 0.42) (Table 1).
correlation of right heart catheterization 
data and diagnosis with LA size 
on cT chest
The average time between the RHC and CT chest was 
17 ± 34 days. The PCWP was 12 ± 6 mmHg in Group I and 
21 ± 7 mmHg in Group II (P = 0.001).
In Group I, 24 subjects had normal PCWP and 5 subjects 
had elevated PCWP on the RHC. Of the 5 subjects with 
elevated PCWP, 3 had impaired LV relaxation with pre-
served LV ejection fraction (LVEF) (range 60%–70%), 2 had 
elevated filling pressures on the echocardiogram suggestive 
of LHD, and the remaining 2 of the 5 subjects had normal 
LV filling pressures, LV relaxation, and LA size (Figure 2). 
In 1 subject with elevated PCWP and a diagnosis of PAH, 
the RHC revealed marked elevation of both central venous 
pressure and right ventricular end-diastolic pressure and 
echocardiogram demonstrated a small LV with cavitary 
compromise due to markedly abnormal paradoxical interven-
tricular systolic motion secondary to right ventricle systolic 
pressure overload. The second patient had portopulmonary 
hypertension and a high cardiac output that may have con-
tributed to the high PCWP.
In Group II, 7 of the 8 subjects had elevated PCWP at time 
of RHC (Figure 2); 1 subject with normal PCWP also had 
normal PA pressures during the RHC. This indicates that in 
all but 1 subject with a large appearing LA on the CT chest, 
also had elevated PCWP.
Subjective observer impression of LA size correlated 
with PCWP (R = 0.51, P = 0.001). There was a positive 
correlation between the subjective observer impression of 
Table 1 Baseline characteristics of the 37 subjects
Group I Group II P value
number of subjects, n 29 8
Age, yr 47 ± 14 67 ± 7 0.0009
Females, n (%) 24 (83) 6 (75) 0.019
Race, n – – –
caucasian 16 6 0.132
hispanic 7 0 0.352
African-American 5 2 0.435
creatinine, mg/dL 0.98 ± 0.22 1.0 ± 0.13 0.81
Body surface area, m2 1.98 ± 0.24 1.94 ± 0.29 0.73
Body mass index, kg/m2 30 ± 12 32.5 ± 11 0.63
heart rate, beats.min-1 85 ± 13 75 ± 12 0.056
Mean arterial pressure, mmhg 86 ± 15 85 ± 9 0.76
Mean pulmonary artery 
pressure, mmhg
46 ± 13 42 ± 13 0.42
cardiac index, L/min/m2 2.68 ± 1.15 3.23 ± 0.92 0.204
LVeF, % 63 ± 5 56 ± 9 0.009
MVO2, % 63 ± 12 66 ± 13 0.598
Note:   Values expressed as mean ± SD.
Abbreviations: LA,  left atrium;  LVeF,  left ventricular ejection fraction; MVO2, mixed 
venous oxygen consumption.
Table 2 LA area by cT by each investigator, uncorrected (A), and 
corrected (B)
A.
Investigator Uncorrected LA area (cm2) P value
Group I Group II
1 19.46 ± 4.7 41.05 ± 9.7 0.002
2 19.19 ± 5.8 39.05 ± 3.6 0.002
3 19.44 ± 6 39.68 ± 12 0.002
B.
Investigator Corrected LA area (cm) P value
Group I Group II
1 0.78 ± 0.12 1.68 ± 0.32 0.002
2 0.77 ± 0.22 1.61 ± 0.14 0.002
3 0.78 ± 0.23 1.63 ± 0.47 0.002
Note: Data values expressed as mean ± SD.
Abbreviation: LA, left atrium.International Journal of General Medicine 2010:3 26
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LA size on the CT chest and LA size on measured echocar-
diogram (R = 0.61, P  0.001). The positive predictive value 
(PPV) of the LA size in determining elevated PCWP in PH 
subjects was 87.5%; negative predictive value (NPV) was 
83%. PPV of LA size on CT chest in determining LA size 
on echocardiogram was 90%; NPV was 67%. These results 
suggest that looking at the LA on the CT chest may be an 
indicator of elevated PCWP.
Measurement of LA area and PcWP
Pearson correlation analysis was conducted to determine 
whether increased LA area correlated with PCWP. There was 
a significant correlation between PCWP and estimated LA 
area, both uncorrected (R = 0.45, P = 0.005) and corrected 
(R = 0.47, P = 0.003) (Figure 3). This result indicates that 
the LA area increases as the PCWP became elevated and 
may be an important indicator of elevated PCWP. It also 
suggests that there is no need to correct a LA size measure-
ment for parameters of patient size.
Though no patient had a LVEF  45%, uncorrected LA 
area negatively correlated with LVEF (R = –0.34, P = 0.03) 
(Table 3) suggesting that as LVEF decreased not unexpectedly 
LA area increased. This provides some internal consistency 
and clinical validation of the observation.
To determine if LA area on a CT chest could be used 
to discriminate between subjects with PAH (diagnostic 
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Figure 3 correlation between PcWP and left atrial area – uncorrected (A) and corrected (B).   There were 3 subjects with markedly elevated PcWP (37, 35 and 32 mmhg) 
with elevated LA area and had final diagnosis as diastolic dysfunction.
Abbreviations: LA, left atrium; PcWP, pulmonary capillary wedge pressure.
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Figure 2 computed tomography of chest impression of LA in subjects undergoing 
right heart catheterization for pulmonary hypertension evaluation. Group I, small-
normal appearing LA. Group II large appearing LA. In group I, there were 3 subjects with 
small-normal appearing LA and elevated PcWP with the evidence of left ventricular 
dysfunction. Normal PCWP defined as equal to or less than 15 mmHg and elevated 
PcWP as greater than 15 mmhg.
Abbreviations: LA, left atrium; PcWP, pulmonary capillary wedge pressure.International Journal of General Medicine 2010:3 27
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group I) from those with elevated PCWP (diagnostic 
group II), we calculated area under the receiver operating 
characteristic (ROC) curves for both uncorrected and 
corrected LA area. The largest area under the ROC for uncor-
rected LA area of 31 cm2 was 0.996 (Figure 4). Therefore, 
uncorrected LA area of 31 cm2 may be a good diagnostic 
tool to discriminate between the two groups. Value greater 
than 1.3 for the corrected LA area yielded a sensitivity and 
specificity for prediction of left heart failure with preserved 
EF of 100%. These promising results indicate that both 
uncorrected and corrected LA area measurements were 
reasonable values to distinguish between subjects with 
elevated PCWP (diagnostic group II) and pulmonary arterial 
hypertension (diagnostic group I).
Discussion
Clinical suspicion of PH is usually confirmed by an 
echocardiogram,11 which is typically reliable for discrimi-
nating systolic dysfunction, valvular lesions, and congenital 
defects. CT chest is frequently undertaken as part of the 
routine evaluation of PH patients to exclude parenchymal 
lung disease. Estimation or measurement of LA size by 
CT chest is simple and remarkably reliable, akin to the 
routine evaluation of heart size from chest X-ray. This study 
demonstrates the utility of routinely assessing LA size/area 
in the evaluation of patients with PH. The data presented 
here indicate that most patients with a large LA on CT chest, 
even without formal measurement, had elevated PCWP 
suggestive of LHD. These findings may allow patients to 
be stratified for risk of PAH enabling prioritization for right 
heart catheterization and evaluation of the need for initiation 
of PH specific therapy. In addition inappropriate use of PAH 
specific therapy could be avoided.4
PAH is an orphan disease with a prevalence of 15 cases 
per million.12 In this single center study we present data from 
37 patients who underwent both RHC and CT chest within 
1 month of each other. There were 26 patients with PAH in 
Group I, 7 patients had LHD with preserved ejection fraction 
in Group II. 1 patient in Group II had normal pulmonary 
artery pressures and PCWP. Three patients in Group I were 
diagnosed with LHD with preserved ejection fraction based 
on the findings of impaired LV relaxation on the echocar-
diogram in all 3 and elevated filling pressures in 2 of the 
3 subjects. One of the patients in Group I with elevated 
PCWP and small appearing LA on CT chest had markedly 
enlarged right atrium and right ventricle, and small LV with 
Table 3 Pearson’s correlation analysis of clinical and hemodynamic parameters with LA area (uncorrected and corrected)
Parameter R (uncorrected LA area) R (corrected LA area)
Age, years -0.08 (0.60) -0.06 (0.68)
Body mass index, kg/m2 -0.178 (0.30) -0.224 (0.19)
Mean arterial pressure, mmhg -0.238 (0.15) -0.211 (0.21)
Mean pulmonary artery pressure, mmhg -0.208 (0.21) -0.182 (0.28)
cardiac output, L/min -0.032 (0.85)   0.008 (0.96)
cardiac index, L/min/m2 -0.011 (0.95) -0.050 (0.77)
LVeF, % -0.345 (0.03)* -0.274 (0.10)
MVO2, % -0.142 (0.40) -0.133 (0.44)
Notes: Pearson correlation (significance); *P  0.05.
Abbreviations: LA, left atrium; LVeF, left ventricular ejection fraction; MVO2, mixed venous oxygen consumption.
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Figure 4 Receiver operating characteristic curve for distinguishing Group I and Group II 
based on the uncorrected LA area on the computed tomography of the chest.
Abbreviations: AUc, area under the receiver operating characteristic curve; 
LA, left atrium.International Journal of General Medicine 2010:3 28
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shifting of the interventricular septum towards LV on the 
echocardiogram. This may reflect ventricular interdependence 
with elevated right ventricular pressure and volume shifting 
the interventricular septum to the left leading to obliteration 
of the LV cavity and LV systolic/diastolic dysfunction. This 
phenomenon, also known as the “reverse Bernheim effect”, is 
increasingly recognized in PAH populations.13,14 The elevated 
PCWP in left heart failure with preserved EF, on the other 
hand, is due to the stiffened LV with decrease compliance 
and associated with enlargement of the LA.15 In such cases, 
LHD results from noncompliance of the LV , which in the 
presence of normal LV systolic function, produces elevated 
left ventricular filling pressures (elevated PCWP or LV end-
diastolic pressures),16 further aggravated by increases in heart 
rate in response to effort or stress. LHD with preserved EF 
is the commonest confounding diagnosis in the evaluation 
and management of patients with PH and an increasingly 
frequent diagnostic entity in the aging, diabetic, and hyper-
tensive population. Evaluation of echographic parameters 
of LHD is beyond the scope of this paper and will be under-
taken in subsequent studies.
LA size is considered a marker of LHD with preserved 
ejection fraction.7–10 Advancing age alone does not contribute 
to LA enlargement and the impact of gender on LA volume 
may be due to differences in body surface area.8 However, 
in our study there was no difference in the body surface area 
or body mass index between the two groups (Table 1). Factors 
influencing LA size include valvular abnormalities and atrial 
arrhythmias.17 None had atrial fibrillation at the time of RHC. 
Prevalence of LHD with preserved EF is high and treatment 
remains poorly defined, risk factors include: essential hyper-
tension, obesity, obstructive sleep apnea, renal failure, thyroid 
dysfunction, female gender, and older age.16,18,19
Patients may be presumptively started on PAH specific 
therapy without undergoing a diagnostic RHC. A CT chest, 
however, can be easily and non-invasively undertaken and 
our data indicates LA size could give an indication of the 
presumed diagnosis pending RHC. The impression of LA 
enlargement on CT in patients undergoing evaluation for 
PH may be an important predictor that PH specific therapy 
was not indicated. This data should not be construed as a 
recommendation to base diagnosis of PH on CT chest without 
proceeding to RHC but rather to identify patients at risk of 
LHD with enlarged LA.
Different imaging techniques such as 2- or 3-dimensional 
echocardiography, magnetic resonance imaging, and cine 
computerized tomography, have been used to estimate 
LA size and/or volume.20–23 These techniques are limited 
by availability, technical difficulties, time requirements, 
or need for special software.20,24 Though tertiary care centers 
have the ability to undertake an echocardiography evaluation 
of patients with suspected PH, such studies have not been 
validated in large trials nor are they routinely applied to all 
echocardiograms evaluations.25–27 Our data demonstrate that 
a routine CT chest may be used to reliably predict elevated 
PCWP that may suggest the diagnosis of LHD in patients 
with preserved LV systolic function and echocardiograhic 
evidence of PH.
Conclusion
Estimation of LA size by CT chest may avoid initiation 
of unnecessary and inappropriate PH-specific therapy 
and delays in diagnostic RHC in patients undergoing PH 
evaluation.
Limitations of the study
The limitations of this study were the retrospective study 
design, small sample size, and one center review. LA area 
and impression may have been influenced by the cardiac cycle 
at the time of the CT chest and intravascular volume status 
of the patient. However, these determinations are beyond 
the scope of this study. Furthermore, future studies that pro-
spectively and simultaneously evaluate the echocardiographic 
and hemodynamic parameters in patients undergoing PH 
evaluation will be needed. The results of this single-center 
study will need to be validated in a large prospective multi-
center study.
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